Advanced Forum ViewPharmaceutical Jobs Healthcare Social Network

Forum Topic News

Search in the sub-forums

News

338 conversations, 340 comments, 13,418 views

- Latest Comments
  
  Comments/Views
  
  Conversations
- by PHARMeMED Admin
  
  February 4
  
  1 / 29
  
  'Green' Medical Propellant Receives FDA Approval to Proceed to Clinical Trials
  
  Posted on February 4 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  April 8, 2019
  
  1 / 379
  
  Researchers Report SX-682 Could Enhance Multiple Forms of T Cell-Based Immunotherapies in Solid Tumors
  
  Posted on April 8, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  April 5, 2019
  
  1 / 777
  
  Indivior's RECOVER™ Study Finds Three-quarters of Patients with Moderate to Severe Opioid Use Disorder Who Received 12 monthly I...
  
  Posted on April 5, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  March 29, 2019
  
  1 / 345
  
  Luye Pharma's Rykindo® Expected to Be the First Chinese Innovative Drug to Receive U.S. FDA Approval
  
  Posted on March 29, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  March 26, 2019
  
  1 / 334
  
  Johnson & Johnson Vision's Investigational Antihistamine-Releasing Contact Lens Demonstrates Positive Phase 3 Results
  
  Posted on March 26, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  March 15, 2019
  
  1 / 328
  
  Interim Analysis Showed Treatment with OPSUMIT® (macitentan) Associated with Significant Improvement in Right Ventricular (RV) F...
  
  Posted on March 15, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  March 12, 2019
  
  1 / 339
  
  AARP Launches 'Stop Rx Greed' Campaign Targeting High Prescription Drug Prices
  
  Posted on March 12, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  March 5, 2019
  
  1 / 361
  
  AnTolRx Announces Pfizer Exercises Option To License Immune Tolerance Therapy For Potential Treatment Of Type 1 Diabetes
  
  Posted on March 5, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 22, 2019
  
  1 / 350
  
  Enzychem Lifesciences Completes Stage 1 Patient Enrollment in Phase 2 CRIOM Study
  
  Posted on February 22, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 21, 2019
  
  1 / 353
  
  Amgen, Cytokinetics And Servier Announce Start Of METEORIC-HF, The Second Phase 3 Clinical Trial Of Omecamtiv Mecarbil In Patien...
  
  Posted on February 21, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 7, 2019
  
  1 / 367
  
  Paramount Developments Crucial for Advancing Clinical Trials Targeting Cancer Treatments
  
  Posted on February 7, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 4, 2019
  
  1 / 358
  
  Takeda to Highlight Advancements in Rare Lysosomal Storage Disorders at Global Scientific Meeting
  
  Posted on February 4, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 1, 2019
  
  1 / 406
  
  Janssen Enters Worldwide Collaboration and License Agreement with MeiraGTx to Develop Gene Therapy Programs for Inherited Retina...
  
  Posted on February 1, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  February 1, 2019
  
  1 / 394
  
  FDA Expands Lilly's ALIMTA® (pemetrexed) Label with Combination of KEYTRUDA® (pembrolizumab) and Platinum Chemotherapy for the F...
  
  Posted on February 1, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 30, 2019
  
  1 / 366
  
  See 20+ case studies of pharma creating value for patients and healthcare
  
  Posted on January 30, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 25, 2019
  
  1 / 384
  
  Merck KGaA, Darmstadt, Germany, Grants Exclusive License to Vertex for Two DNA Damage Response Inhibitors
  
  Posted on January 25, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 23, 2019
  
  1 / 386
  
  Biohaven Receives FDA May Proceed Letter For Phase 3 Clinical Trial Of BHV-3241 For Multiple System Atrophy
  
  Posted on January 23, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 21, 2019
  
  1 / 361
  
  Lilly Phase 3 REACH-2 Trial Data Published in The Lancet Oncology Shows Improvement in Overall Survival with CYRAMZA® (ramucirum...
  
  Posted on January 21, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 9, 2019
  
  1 / 376
  
  EVENITY™ (romosozumab) Receives Approval In Japan For The Treatment Of Osteoporosis In Patients At High Risk Of Fracture
  
  Posted on January 9, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  January 6, 2019
  
  1 / 399
  
  Uni-Bio Science's Anti-diabetic Acarbose Oral Tablets BE Study Application Accepted by the National Medical Products Administrat...
  
  Posted on January 6, 2019 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  December 14, 2018
  
  1 / 478
  
  FDA Grants Fast Track Designation to the Baricitinib Development Program for the Treatment of Systemic Lupus Erythematosus (SLE)
  
  Posted on December 14, 2018 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  December 13, 2018
  
  1 / 438
  
  16S Next Generation Sequencing Bacterial Meningitis test from Viracor Eurofins provides actionable results to improve patient ou...
  
  Posted on December 13, 2018 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  December 10, 2018
  
  1 / 429
  
  Biohaven Announces Positive Results from Ongoing Rimegepant Long-Term Safety Study
  
  Posted on December 10, 2018 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  December 4, 2018
  
  1 / 435
  
  CAR T-Cell Treatment
  
  Posted on December 4, 2018 by PHARMeMED Admin
  
  by PHARMeMED Admin
  
  December 3, 2018
  
  1 / 470
  
  FDA approves first treatment for Lambert-Eaton myasthenic syndrome (LEMS) in adults
  
  Posted on December 3, 2018 by PHARMeMED Admin
  Mark All as Read
  
  Quick navigation
  1
  
  2
  
  3
  
  4
  
  5
  
  6
  
  7
  
  8
  
  9
  
  10
  
  Next »

Sign In or Join

News